Content about Tetrahydrocannabinol

June 15, 2012
Valeant to acquire OraPharma in $312 million deal

Valeant Pharmaceuticals International has agreed to acquire a specialty oral health company that develops and commercializes products that improve and maintain oral health.

MONTREAL — Valeant Pharmaceuticals International has agreed to acquire a specialty oral health company that develops and commercializes products that improve and maintain oral health.

Valeant said it is acquiring OraPharma from private equity firm Water Street Healthcare Partners for $312 million. The drug maker also said it will pay $114 million in potential contingent payments based on certain milestones.

May 15, 2012
Cardinal Health settles dispute with DEA over Florida distribution center

Cardinal Health on Tuesday announced it had agreed to a settlement with the Drug Enforcement Agency that allows the company to bring resolution to ongoing litigation.

DUBLIN, Ohio — Cardinal Health on Tuesday announced it had agreed to a settlement with the Drug Enforcement Agency that allows the company to bring resolution to ongoing litigation.

May 7, 2012
Purdue Pharma launches free educational resource to combat drug abuse

Drug maker Purdue Pharma has introduced a new educational resource for healthcare professionals designed to curb the abuse of prescription drugs, the company said Monday.

STAMFORD, Conn. — Drug maker Purdue Pharma has introduced a new educational resource for healthcare professionals designed to curb the abuse of prescription drugs, the company said Monday.

December 28, 2010
Report: More than a quarter of U.S. kids take at least one chronic med

Health professionals worry that little is known about the long-term effects of many drugs — which have been tested extensively on adult-patient populations — on children.

NEW YORK — More than 25% of children and teens take at least one medication on a daily basis, and nearly 7% are on two or more drugs, the Wall Street Journal reported Tuesday, citing 2009 data from Medco Health Solutions. Drawing additional data from IMS Health, the article noted that prescriptions for hypertension in people under the age of 20 years could reach 5.5 million for 2010 by the time year-end results are tabulated, which would mark a rise of 17% since 2007. 

July 5, 2010
FDA approves Purdue Pharma's analgesic

Purdue Pharma has received approval from the Food and Drug Administration for its analgesic product...

March 11, 2010
FDA adds boxed warning to Plavix

A popular drug for preventing blood clots may be less effective when taken by a...